Related Experiment Videos

[Usefulness of early-stage intervention in mild hypertension: evidence from large-scale clinical trials]

Takanao Hashimoto1, Takayoshi Ohkubo, Yutaka Imai

  • 1Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 15, 2008
PubMed

Insights

Stage 1 hypertension, defined as blood pressure 140-159/90-99 mmHg, is a cardiovascular risk. Antihypertensive treatment shows benefits, particularly for high-risk patients, but optimal drug choices require further research.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Internal Medicine

Context:

  • Mild hypertension (Stage 1) is defined as systolic blood pressure 140-159 mmHg and/or diastolic blood pressure 90-99 mmHg.
  • Established hypertension guidelines recognize it as a cardiovascular event risk factor.
  • While treatment for moderate/severe hypertension is well-established, mild hypertension requires further investigation.

Purpose:

  • To review the current understanding of mild hypertension as a cardiovascular risk factor.
  • To evaluate the evidence for antihypertensive treatment in mild hypertension.
  • To identify knowledge gaps regarding optimal drug selection for mild hypertension.

Summary:

  • Mild hypertension (Stage 1) poses a significant risk for cardiovascular events.
  • Recent trials indicate antihypertensive treatment reduces cardiovascular risk in mild hypertension patients, especially those with prior cardiovascular disease or diabetes.
  • Further research is needed to determine the most effective antihypertensive drugs for this population.

Impact:

  • Highlights the importance of managing mild hypertension to prevent cardiovascular events.
  • Informs clinical practice regarding the potential benefits of antihypertensive therapy in specific mild hypertension patient groups.
  • Guides future research priorities in hypertension management and pharmacotherapy.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...